NSEGeneral Updates30 Jun 2026 · 30 Jun 2026, 11:54 am

General Updates

Mankind Pharma Limited · MANKIND

✦ AI SummaryResults

Mankind Pharma Limited has scheduled its 35th Annual General Meeting (AGM) on August 4, 2026, through video conferencing. The notice and annual report for the financial year 2025-26 will be dispatched to members in due course.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Mankind Pharma Limited has informed the Exchange about General Updates

Attachments (1)

📄

MANKIND1_30062026115440_Intimation_of_AGM_sd.pdf

pdf

Download →
View document text
June 30, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: Mankind Dear Sir/ Madam, Subject: Intimation of the date of Thirty Fifth (35th) Annual General Meeting of the Company With reference to the captioned subject, we wish to inform you that the 35th Annual General Meeting (“AGM”) of the Members of Mankind Pharma Limited (“the Company”) is scheduled to be held on Tuesday, August 4, 2026 at 03:30 p.m. (IST) through Video Conferencing/ Other Audio-Visual Means in compliance with the applicable provisions of the Companies Act, 2013 (the “Act”) and the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. Kindly note that Notice of the AGM along with Annual Report for the financial year 2025-26 will be dispatched to the Members in due course in compliance with the applicable provisions of the Act, relevant circulars and Listing Regulations. Above information shall also be available on the website of the Company i.e. www.mankindpharma.com. You are requested to take the above information on your record. Thanking You, Yours Sincerely, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer